Promacta, Doribax Applications Get Advisory Committee Reviews
This article was originally published in The Pink Sheet Daily
Executive Summary
Amgen’s Enbrel will also be reviewed for a pediatric psoriasis indication.
You may also be interested in...
FDA Notes Theoretical Cancer Risk For Centocor’s Ustekinumab
MAb for psoriasis has favorable odds for a June 17 recommendation by advisory panel, analysts say.
FDA Notes Theoretical Cancer Risk For Centocor’s Ustekinumab
MAb for psoriasis has favorable odds for a June 17 recommendation by advisory panel, analysts say.
Europe Likes Schering’s Bridion, But Not Takeda’s Rozerem
New opinion includes CHMP skepticism of insomnia drug.